Trading In Novo Nordisk A/S Shares By Board Members, Executives And Associated Persons On 11 August 2017

Published: Aug 14, 2017

Bagsværd, Denmark, 14 August 2017 - This document discloses the data of the transaction(s) made in Novo Nordisk shares by the company's board members, executives and their associated persons in accordance with Article 19 of Regulation No. 596/2014 on market abuse.

The company's board members, executives and their associated persons have given Novo Nordisk power of attorney on their behalf to publish trading in Novo Nordisk shares by the company's board members, executives and their associated persons.


Further information

Media:
Katrine Sperling +45 4442 6718 krsp@novonordisk.com
Ken Inchausti (US) +1 609 786 8316 kiau@novonordisk.com
Investors:
Peter Hugreffe Ankersen +45 3075 9085 phak@novonordisk.com
Hanna Ögren +45 3079 8519 haoe@novonordisk.com
Anders Mikkelsen +45 3079 4461 armk@novonordisk.com
Christina Jensen +45 3079 3009 cnje@novonordisk.com
Kasper Veje (US) +1 609 235 8567 kpvj@novonordisk.com

Company announcement No 63 / 2017

Attachments:

http://www.globenewswire.com/NewsRoom/AttachmentNg/f7247feb-edee-4999-ba5b-4bb4d2e99bf1

Back to news